Shielding of the contralateral breast during tangential irradiation

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 27, Issue 4, 2004, Pages 436-439

  Goffman, Thomas E ^a,b   Miller, Michael ^a   Laronga, Christine ^a   Oliver, Shelly ^a   Wong, Ping ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

Breast cancer; Breast irradiation; Breast shielding; Radiogenic breast cancer

Indexed keywords

LEAD;

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; IRRADIATION; PHANTOM; RADIATION DOSE; RADIATION EXPOSURE; RADIATION SHIELD; THICKNESS;

ADULT; BREAST NEOPLASMS; HUMANS; LEAD; MIDDLE AGED; PHANTOMS, IMAGING; RADIATION PROTECTION;

EID: 3843144249     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000128720.56101.81     Document Type: Article

References (25)

1. Kutcher GJ, Smith AR, Fowble BL, et al. Treatment planning for primary breast cancer: a patterns of care study. Int J Radiat Oncol Biol Phys. 1996;36:731-737.
2. Tokunaga M, Norman JE Jr, Asano M, et al. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74. J Natl Cancer Inst. 1979;62:1347-1359.
3. Howe GR, McLaughlin J. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat Res. 1996;145:694-707.
4. Hrubec Z, Boice JD Jr, Monson RR, et al. Breast cancer after multiple chest fluoroscopies: second follow-up of Massachusetts women with tuberculosis. Cancer Res. 1989;49:229-234.
5. Simon N. Breast cancer induced by radiation. Relation to mammography and treatment for acne. JAMA. 1977;237:789-790.
6. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst. 1995;85:25-31.
7. Yahalom J, Petreck JA, Biddinger PW, et al. J Clin Oncol. 1992;10: 1674-1681.
8. Gervais-Fagnon DD, Girouard C, Laperriere N, et al. Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease. Oncology. 1999;57:224-231.
9. Aisenberg AC, Finkelstein DM, Doppke KP, et al. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer. 1997;79:1203-1210.
10. Boice JD Jr, Land CE, Shore RE, et al. Risk of breast cancer following low-dose radiation exposure. Radiology. 1979;131:589-597.
11. Tokunaga M, Land CE, Yamamoto T, et al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980. Radiat Res. 1987;12:243-272.
12. Boice JD Jr, Harvey EB, Blettner M, et al. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med. 1992;326: 781-785.
13. Fraass BA, Roberson PL, Lichter AS. Dose to the contralateral breast due to primary breast irradiation. Int J Radiat Oncol Biol Phys. 1985; 11:485-497.
14. Macklis RM, Crownover RL, Crowe J, et al. Reducing scatter radiation to the contralateral breast with a mobile, conformal shield during breast cancer radiotherapy. Am J Clin Oncol. 1999;22:419-425.
15. Muller-Runkel R, Kalokhe UP. Method for reducing scatter radiation dose to the contralateral breast during tangential breast irradiation therapy. Radiology. 1994;191:853-855.
16. Jamal N, Das KR. Measurement of dose to the contralateral breast during radiation therapy for breast cancer: reduction by the use of superflab. Australas Phys Eng Sci Med. 2001;24:102-105.
17. Khan AJ, Haffty BG. The location of contralateral breast cancers after radiation therapy. Breast J. 2001;7:331-336.
18. Strom HH, Anderrsson M, Boice JD Jr, et al. Adjuvant radiotherapy and risk of contralateral breast cancer. J Natl Cancer Inst. 1992;84:1245-1250.
19. Feig SA, Hendrick RE. Radiation risk from screening mammography of women aged 40-49 years. J Natl Cancer Inst Monogr. 1977;22:119-124.
20. Julien JP, Bijkerr N, Fentiman IS, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase III trial. Lancet. 2000;355:528-533.
21. Tercilla O, Krasin F, Lawn-Tsao L. Comparison of contralateral breast doses from [1/2] beam block and isocentric treatment techniques for patients treated with primary breast irradiation with 60CO. Int J Radiat Oncol Biol Phys. 1989;17:205-210.
22. Brooks PS. Dose to contralateral breast-a comparative study. Med Dosim. 1995;20:301-307.
23. Kelly CA, Wang XY, Chu JC, et al. Dose to contralateral breast: a comparison of four primary breast irradiation techniques. Int J Radiat Oncol Biol Phys. 1996;34:727-732.
24. Epstein RJ, Kelly SA, Cook M, et al. Active minimisation of radiation scatter during breast radiotherapy: management implications for young patients with good-prognosis primary neoplasms. Radiother Oncol. 1996;40:69-74.
25. Warlick WB, O'Rear JH, Earley L, et al. Dose to the contralateral breast: a comparison of two techniques using the enhanced dynamic wedge versus a standard wedge. Med Dosim. 1997;22:185-191.